يعرض 1 - 10 نتائج من 20 نتيجة بحث عن '"Katare, Sagar"', وقت الاستعلام: 0.92s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Real-world assessment of effectiveness and safety profile of remogliflozin etabonate in management of type 2 diabetes mellitus

    المؤلفون: Sethi, Bipin, Chowdhury, Subhankar, Bhattacharya, Supratik, Katare, SagarAff4, IDs13410022010743_cor4, Suryawanshi, Sachin, Barkate, Hanmant

    المصدر: International Journal of Diabetes in Developing Countries: Incorporating Diabetes Bulletin. 43(2):214-225

    Find this article in full text from Springer Verlag. Full Text Finder
    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Assessment of safety and tolerability of remogliflozin etabonate (GSK189075) when administered with total daily dose of 2000 mg of metformin

    المؤلفون: Robert Dobbins, Elizabeth K. Hussey, Robin O’Connor-Semmes, Susan Andrews, Wenli Tao, William O. Wilkison, Bentley Cheatham, Katare Sagar, Barkate Hanmant

    المصدر: BMC Pharmacology and Toxicology, Vol 22, Iss 1, Pp 1-11 (2021)

    مصطلحات موضوعية: Lactic acidosis, Metformin, Pharmacokinetics, Pharmacodynamics, Remogliflozin etabonate, Remogliflozin, Therapeutics. Pharmacology, RM1-950, Toxicology. Poisons, RA1190-1270

    وصف الملف: electronic resource

    Relation: https://doaj.org/toc/2050-6511

    URL الوصول: https://doaj.org/article/ee619324b38a44d88d714cf84257f4f3

    Find this article in full text from Springer Verlag. Find this article in full text from ProQuest Full Text Finder
    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    Efficacy and Safety of Remogliflozin Etabonate, a New Sodium Glucose Co-Transporter-2 Inhibitor, in Patients with Type 2 Diabetes Mellitus: A 24-Week, Randomized, Double-Blind, Active-Controlled Trial

    المؤلفون: Dharmalingam, Mala, Aravind, S. R., Thacker, Hemant, Paramesh, S., Mohan, Brij, Chawla, Manoj, Asirvatham, Arthur, Goyal, Ramesh, Shembalkar, Jayashri, Balamurugan, R., Kadam, Pradnya, Alva, Hansraj, Kodgule, Rahul, Tandon, Monika, Vaidyanathan, Sivakumar, Pendse, Amol, Gaikwad, Rajesh, Katare, SagarAff13, Suryawanshi, Sachin, Barkate, Hanmant

    المصدر: Drugs. 80(6):587-600

    Find this article in full text from Springer Verlag. Find this article in full text from ProQuest Full Text Finder
    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    An Open-Label, Single-Period, Two-Stage, Single Oral Dose Pharmacokinetic Study of Remogliflozin Etabonate Tablet 100 and 250 mg in Healthy Asian Indian Male Subjects Under Fasting and Fed Conditions

    المؤلفون: Joshi, Shashank, Gudi, Girish, Menon, Vinu C. A., Tandon, Monika, Joshi, Vikas, Suryawanshi, Sachin, Barkate, Hanmant, Sawant, Nikhil, Katare, SagarAff6, Siddique, Waseem

    المصدر: Clinical Pharmacokinetics. 59(3):349-357

    Find this article in full text from Springer Verlag. Find this article in full text from ProQuest Full Text Finder
    أضف إلى المفضلة
  5. 5
    Assessment of safety and tolerability of remogliflozin etabonate (GSK189075) when administered with total daily dose of 2000 mg of metformin

    المؤلفون: Barkate Hanmant, Robert Dobbins, Susan Andrews, Bentley Cheatham, Robin O'Connor-Semmes, Elizabeth Hussey, Katare Sagar, Wenli Tao, William O. Wilkison

    المصدر: BMC Pharmacology and Toxicology, Vol 22, Iss 1, Pp 1-11 (2021)
    BMC Pharmacology & Toxicology

    مصطلحات موضوعية: Blood Glucose, Male, Blood Pressure, Pharmacology, 030226 pharmacology & pharmacy, chemistry.chemical_compound, 0302 clinical medicine, Glucosides, Remogliflozin, RA1190-1270, Insulin, Pharmacology (medical), Drug Interactions, Lactic acidosis, SGLT2 inhibitor, Fasting, Middle Aged, Metformin, Glycemic index, Tolerability, Drug Therapy, Combination, Female, Safety, medicine.drug, Research Article, Adult, Remogliflozin etabonate, 030209 endocrinology & metabolism, RM1-950, Placebo, 03 medical and health sciences, Pharmacokinetics, Double-Blind Method, Type 2 diabetes mellitus, medicine, Humans, Hypoglycemic Agents, Lactic Acid, Adverse effect, business.industry, Sodium-glucose transporters (SGLTs), chemistry, Diabetes Mellitus, Type 2, Pharmacodynamics, Toxicology. Poisons, Pyrazoles, Therapeutics. Pharmacology, business

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bc3a4e5498b39d7a1a70581e976409b
    https://doaj.org/article/ee619324b38a44d88d714cf84257f4f3

    Find this article in full text from Springer Verlag. Find this article in full text from ProQuest
    أضف إلى المفضلة
  6. 6
    دورية أكاديمية

    لا يتم عرض هذه النتيجة على الضيوف.

    View this record from ISI Web of Science
    أضف إلى المفضلة
  7. 7
    دورية أكاديمية

    لا يتم عرض هذه النتيجة على الضيوف.

    View this record from ISI Web of Science
    أضف إلى المفضلة
  8. 8
    دورية
    Potential Risks and Mitigation Strategies During the Conduct of a Clinical Trial: An Industry Perspective

    المؤلفون: Bhagat, Seema, Kapatkar, Vaibhavi, Katare, Sagar, Mane, Ashish, Pinto, Colette, Pawar, Kedar, Shah, Agam, Barkate, Hanmant

    المصدر: Reviews on Recent Clinical Trials; March 2018, Vol. 13 Issue: 1 p52-60, 9p

    أضف إلى المفضلة
  9. 9
    دورية أكاديمية

    لا يتم عرض هذه النتيجة على الضيوف.

    View this record from ISI Web of Science
    أضف إلى المفضلة
  10. 10
    دورية أكاديمية
    800-P: Phase 3 Results of Fixed-Dose Combination of Remogliflozin Etabonate and Vildagliptin in Indian T2DM Patients.

    المؤلفون: MOHAN, BRIJ, CHAWLA, MANOJ S., KODGULE, RAHUL R., TANDON, MONIKA, KATARE, SAGAR, SURYAWANSHI, SACHIN, BARKATE, HANMANT V.

    المصدر: Diabetes; 2021 Supplement 1, Vol. 70, pN.PAG-N.PAG, 1p

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء